National Institutes of Health psilocybin research speaker series: State of the science, regulatory and policy landscape, research gaps, and opportunities.
Neuropharmacology June 1, 2023 Dan Xi, Ann Berger, David Shurtleff et al. 11 citations
In 2021, the U.S. National Institutes of Health (NIH) held its first-ever speaker series focused on a psychedelic substance, titled the 'NIH Psilocybin Research Speaker Series,' from April 22 to June 10. The series aimed to provide evidence-based information to the public and scientific community, assess the current state of psilocybin science, review regulatory and policy landscapes, and identify knowledge gaps to define future research needs. Highlights from lectures and discussions by 26 national and international experts formed the basis for a Special Issue of Neuropharmacology.